| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8217530 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 7 Pages |
Abstract
Our study showed that HypoTRT of 55Â Gy at 2.5Â Gy per fraction daily concurrently with etoposide/cisplatin chemotherapy has favorable survival and acceptable toxicity. This radiation schedule deserves further investigation in LS-SCLC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Bing MD, Ling-Zhi MD, Xu-Wei MD, Zheng-Fei MD, Qi MD, Kuai-Le MD, Min MD, Jing-Fang MD, Huan-Jun MD, Kai-Liang MD, Xiao-Long MD,